centchroman has been researched along with dactinomycin in 1 studies
| Studies (centchroman) | Trials (centchroman) | Recent Studies (post-2010) (centchroman) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
|---|---|---|---|---|---|
| 157 | 12 | 47 | 19,045 | 355 | 969 |
| Protein | Taxonomy | centchroman (IC50) | dactinomycin (IC50) |
|---|---|---|---|
| RAD51 | Homo sapiens (human) | 32.1 | |
| Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
| Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balapure, AK; Gupta, DK; Nigam, D; Nigam, M; Ranjan, V; Sharma, R; Singh, N; Sundaram, S; Zaidi, D | 1 |
1 other study(ies) available for centchroman and dactinomycin
| Article | Year |
|---|---|
Centchroman mediated apoptosis involves cross-talk between extrinsic/intrinsic pathways and oxidative regulation.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Centchroman; Cycloheximide; Dactinomycin; Down-Regulation; Estrogen Antagonists; Female; Humans; Immunoprecipitation; Oxidative Stress; Tamoxifen; Up-Regulation | 2010 |